The estimated efficacy of catch-up vaccination on HBsAg seroprevalence in early adulthood was 21 % ( 95 % CI 10 % -30 % ) , substantially weaker than that of the neonatal vaccination ( 72 % , 95 % CI 68 % -75 % ) .